Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients

Title: Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
Authors: Elena Lastraioli; Alessandra Bettiol; Jessica Iorio; Elvira Limatola; Daniele Checcacci; Erica Parisi; Cristina Bianchi; Annarosa Arcangeli; Mauro Iannopollo; Francesco Di Costanzo; Marco Di Lieto
Source: Cells, Vol 12, Iss 11, p 1458 (2023)
Publisher Information: MDPI AG
Publication Year: 2023
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: KRAS; NRAS; liquid biopsy; metastatic colorectal cancer; Cytology; QH573-671
Description: In this study we evaluated both~ K- and N- RAS mutations in plasma samples from patients with metastatic colorectal cancer by means of the BEAMing technology, and we assessed their diagnostic performance compared to RAS analyses performed on tissue. The sensitivity of BEAMing in identifying KRAS mutations was of 89.5%, with a fair specificity. The agreement with tissue analysis was moderate. The sensitivity for NRAS was high with a good specificity, and the agreement between tissue analysis and BEAMing was fair. Interestingly, significantly higher mutant allele fraction (MAF) levels were detected in patients with G2 tumors, liver metastases, and in those who did not receive surgery. NRAS MAF level was significantly higher in patients with mucinous adenocarcinoma and for those with lung metastases. A sharp increase in the MAF values was observed in patients who moved towards disease progression. More strikingly, molecular progression always anticipated the radiological one in these patients. These observations pave the way to the possibility of using liquid biopsy to monitor patients during treatment, and to enable oncologists to anticipate interventions compared to radiological analyses. This will allow time to be saved and ensure a better management of metastatic patients in the near future.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/2073-4409/12/11/1458; https://doaj.org/toc/2073-4409; https://doaj.org/article/ae1ad3dff9b4426e8f30f8181f5e4ce9
DOI: 10.3390/cells12111458
Availability: https://doi.org/10.3390/cells12111458; https://doaj.org/article/ae1ad3dff9b4426e8f30f8181f5e4ce9
Accession Number: edsbas.8112FDC7
Database: BASE